Stefanie Hultzsch - Concepedia

Author

Stefanie Hultzsch

Charité - Universitätsmedizin Berlin ORCID

Also Known As

S Hultzsch, S. Hultzsch, Stefanie Hultzsch

Publications

248

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin Humboldt-Universität zu Berlin Freie Universität Berlin Berliner Hochschule für Technik

About

Stefanie Hultzsch is an author at Charité - Universitätsmedizin Berlin specializing in public health, pregnancy, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	88
2	Public Health	4	4	88
3	Obstetrics	4	4	88
4	Abortion	2	2	45
5	Reproductive Health	1	1	11

Stefanie Hultzsch

Publications

166

Citations

H-Index

Page 1

	Year	Citations
No evidence of adverse pregnancy outcome after exposure to ibuprofen in the first trimester – Evaluation of the national Embryotox cohort Katarina Dathe, Anne‐Katrin Fietz, Lucas William Pritchard, Reproductive Toxicology Adverse Pregnancy OutcomeAbortionNational Embryotox CohortMaternal ComplicationGynecology	2018	34
Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohort Katarina Dathe, Johanna Frank, Stephanie Padberg, BMC Pregnancy and Childbirth	2022	34
Negligible risk of prenatal ductus arteriosus closure or fetal renal impairment after third‐trimester paracetamol use: evaluation of the German Embryotox cohort Katarina Dathe, J Frank, Stephanie Padberg, BJOG An International Journal of Obstetrics & Gynaecology	2019	27
Safety of diclofenac use during early pregnancy: A prospective observational cohort study Stephanie Padberg, Tatjana Tissen‐Diabaté, Katarina Dathe, Reproductive Toxicology Maternal ComplicationClinical EpidemiologyPediatricsGynecologyMaternal Health	2018	22
Exposure to cox-2 inhibitors (coxibs) during the first trimester and pregnancy outcome: a prospective observational cohort study Katarina Dathe, Stephanie Padberg, Stefanie Hultzsch, European Journal of Clinical Pharmacology First TrimesterCox-2 InhibitorsMaternal Cardiovascular OutcomeMaternal ComplicationClinical Epidemiology	2017	21
Metamizole use during first trimester—A prospective observational cohort study on pregnancy outcome Katarina Dathe, Stephanie Padberg, Stefanie Hultzsch, Pharmacoepidemiology and Drug Safety	2017	17
First trimester naproxen exposure and outcome of pregnancy – A German case series Stefanie Hultzsch, Wolfgang Paulus, Stephanie Padberg, Reproductive Toxicology Trimester Naproxen ExposureGerman Case SeriesAbortionMaternal ComplicationReproductive Health	2021	11

Page 1